Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group.
Articles > Abstract · 2011
Authors: F. ICLI, K. ALTUNDAG, U. COSKUN, S. PAYDAS, G. BASARAN, P. SAIP, G. G. DOGU, Y. ERALP, RÜÇHAN USLU, A. SEVINC, H. ONUR, N. M. MANDEL, C. SEZGIN, Metin ALTINBAŞ, N. GULER, A. ISIKDOGAN, Erhan GÖKMEN, K. UYGUN, Z. USTUNER, A. YAREN
JOURNAL OF CLINICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, 2011, vol 29, pp 629-629